12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers
Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million.
LENSAR (NASDAQ:LNSR) shares increased byread more...
Benzinga
Lensar (LNSR) Q4 2025 Earnings Transcript
@media (max-width: 768px) {
.image-container {
width: 100% !important;
float: none !important;
margin: 0 0 1rem 0 !important;
}
}
Image source: The Mo...
Nasdaq News: Markets
Lensar (LNSR) Q1 2026 Earnings Transcript
@media (max-width: 768px) {
.image-container {
width: 100% !important;
float: none !important;
margin: 0 0 1rem 0 !important;
}
}
Image source: The Mo...
Nasdaq News: Markets
LENSAR, Inc. (NASDAQ:LNSR) Short Interest Update
LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totaling 1,016,420 shares, a growth of 42.2% from the March 15th total of 714,594 shares. Approximately 24.7% of the company's stock are short sold...
MarketBeat
LENSAR (NASDAQ:LNSR) Upgraded at Lake Street Capital
Lake Street Capital raised LENSAR from a "hold" rating to a "buy" rating and set a $10.00 price objective for the company in a research note on Wednesday...
MarketBeat
LENSAR Q4 Earnings Call Highlights
LENSAR (NASDAQ:LNSR) executives used the company's fourth-quarter and full-year 2025 earnings call to outline how the cataract-laser maker plans to reaccelerate growth as a standalone company...
MarketBeat
LENSAR (NASDAQ:LNSR) Releases Earnings Results, Misses Expectations By $0.02 EPS
LENSAR (NASDAQ:LNSR - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.12) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.02). The firm had revenue of $16.03 million for the quarter, compared to analyst estimates of $20.30...
MarketBeat
LENSAR Stock Plunges Alcon Scraps Merger After Prolonged Regulatory Review
Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressure on shares.read more...
Benzinga
Alcon Ends Merger Agreement With LENSAR After FTC Opposition
(RTTNews) - Alcon Inc. (ALC) announced on Monday that it has agreed with LENSAR, Inc. (LNSR) to terminate their previously announced merger agreement...
Nasdaq News: Markets